HDAC9 and melanoma: MC1568 and MC1575 are derivatives of arylyl-pyrrole-hydroxyamide that are selective for class IIa HDAC and HDAC6, respectively, and exhibit antiproliferative effects in estrogen receptor-positive breast cancer cells [86] and human melanoma cells [87].